Imatinib Induced Facial Skin Hyperpigmentation in a Case of Chronic Myelogenous Leukemia
|
|
|
|
|
|
|
|
نویسنده
|
Valizadeh N
|
|
منبع
|
shiraz e-medical journal - 2011 - دوره : 12 - شماره : 3 - صفحه:162 -164
|
|
چکیده
|
Imatinib is a tyrosine kinase inhibitor (tki) which targets bcr-abl protein in patients with chronic myelogenous leukemia (cml) and c-kit in patients with gastrointestinal stromal tu-mors (gists). skin hypopigmentation is reported during imatinib therapy. we present a case of cml who developed skin hyperpigmentation in the face during treatment with imatinib which found chloasma-like appearance.
|
|
کلیدواژه
|
Imatinib ,Skin ,Hyperpigmentation ,Chloasma
|
|
آدرس
|
urmia university of medical sciences, Section of Hematology and Medical Oncology, Department of Medicine, ایران
|
|
پست الکترونیکی
|
nsedaha0@gmail.com
|
|
|
|
|
|
|